Wedbush Downgrades Cerulean Pharma (CERU) to Neutral
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Wedbush earlier downgraded Cerulean Pharma (NASDAQ: CERU) from Outperform to Neutral with a price target of $1.00 (from $9.00).
Shares of Cerulean Pharma closed at $2.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Credit Suisse Downgrades NetApp (NTAP) to Underperform
- B. Riley Downgrades Jabil Circuit (JBL) to Neutral
- Piper Jaffray Downgrades Helen of Troy (HELE) to Neutral
Create E-mail Alert Related CategoriesAnalyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!